SCYNEXIS, Inc. Gains 25%
Mon, Nov 15, 2021 at 05:30 PM
SCYNEXIS, Inc. (SCYX:NASDAQ) rocketted at $6.75, representing a gain of 25%. The stock appeared on our News Catalysts scanner on Wed, Nov 10, 2021 at 07:59 AM in the 'INVESTOR UPDATE' category. From Fri, Oct 29, 2021, the stock recorded 70.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Jun 01, 2021 at $10.25 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About SCYNEXIS, Inc. (SCYX:NASDAQ)
SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.
Top 10 Gainers:
- Casper Sleep Inc. (CSPR:NYSE), 88.45%
- Patriot National Bancorp, Inc. (PNBK:NASDAQ), 50.4%
- Trio-Tech International (TRT:NYSEMKT), 35.96%
- SCYNEXIS, Inc. (SCYX:NASDAQ), 25%
- MTTR (MTTR:NASDAQ), 22.33%
- NEGG (NEGG:NASDAQ), 21.28%
- COCO (COCO:NASDAQ), 21.17%
- SYTA (SYTA:NASDAQ), 21.11%
- SilverSun Technologies, Inc. (SSNT:NASDAQ), 20.5%
- EGLX (EGLX:NASDAQ), 19.05%